Corvus shareholders elect all director nominees, ratify auditor, approve say-on-pay

Corvus Pharmaceuticals, Inc.

Elected Class III directors: Ian T. Clark (20.9M for), Elisha Gould III (22.6M for), Peter Thompson (17.1M for).
Ratified PricewaterhouseCoopers as fiscal 2022 auditor with 35.3M votes for.
Advisory vote on executive compensation approved (22.6M for, 0.4M against).
Shareholders selected 1-year frequency for future say-on-pay votes (22.5M for 1 year).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.